| 000 | 01462 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514033211.0 | ||
| 264 | 0 | _c20021119 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPosthumus, Marcel D | |
| 245 | 0 | 0 |
_aSerum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cMay 2002 |
||
| 300 |
_a883-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 3 _xblood |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSulfasalazine _xadministration & dosage |
| 700 | 1 | _aLimburg, Pieter C | |
| 700 | 1 | _aWestra, Johanna | |
| 700 | 1 | _avan Leeuwen, Miek A | |
| 700 | 1 | _avan Rijswijk, Martin H | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 29 _gno. 5 _gp. 883-9 |
|
| 999 |
_c11920249 _d11920249 |
||